Vector Science & Therapeutics ("Vector" or the "Company") today announced it has entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash payments over time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results